JSC "Unicapital" updated a broker-dealer license
State Securities Committee granted appeal of "Unicapital" to update the broker-dealer license in the securities market. The company operates in the market for 10 years.
In compliance with the law, the license granted for the next five years. The cost of each license is 5,500 manat.
Since 2012 JSC "Unicapital" has stepped up to the retail market of corporate securities. In December, with a volume of 9 million manat it was the fifth in the ranking of brokers in government securities.
On the market today there are 14 securities brokerage and 13 dealer licenses. In the first half of this year, the deadline for brokerage licenses Ltd. "Yap? Kredi Invest", "Brokdil-Az" and "Texnika Capital Management". The first two companies are to upgrade their dealer licenses. - 08D-
Economics
-
As 2024 comes to a close, Azerbaijan finds itself at a crossroads—holding a prominent position in certain sectors of the global economy but still grappling with issues that hinder broader socioeconomic development. From energy exports to logistics corridors, the country has carved out a niche, yet cracks in its socioeconomic fabric are becoming harder to ignore. Let’s delve into the numbers and listen to expert opinions on Azerbaijan's global standing.
-
Azerbaijan began the new year with significant hikes in gas, electricity, water, and medication tariffs, sparking widespread concern among citizens over the financial burden on households. While officials defend the measures as necessary for economic sustainability, critics warn of challenges tied to stagnant wages and pensions.
-
As of January 1, Europe has ceased contract-based transit of Russian gas through Ukraine. Kyiv announced it would not renew agreements to traffic gas from the "aggressor nation" through its territory. The decision marks a pivotal moment in Europe’s efforts to reduce reliance on Russian energy, a dependency that supplied nearly 50% of the continent’s gas imports before the war in Ukraine.
-
Azerbaijan's Tariff Council has approved a decision to regulate the maximum wholesale and retail prices of registered medicines, with the new pricing caps coming into effect on January 2, 2025.
Leave a review